HNN3.0
Register
Register
Register

Biomedical Research Foundation of the Academy of Athens

R&D Institution

www.bioacademy.grAthens, Greece
3 profile visits

About

The Biomedical Research Foundation of the Academy of Athens (BRFAA) is the most recent addition to the Life Sciences Research organizations in Greece, which begun its activities in 2004. It is located at a distance of 3 km from downtown Athens, and is housed in a modern 32,000 m2 building.

The founding principle of BRFAA is to host both basic and clinical research, thus, providing an ideal setting for the emergence of translational activities (Medical Application). BRFAA is one of the few institutes with such character in Europe and is certainly unique for Greece.

The main goal of BRFAA is to achieve excellence in the Biomedical Sciences by recruiting high quality investigators carrying out cutting-edge basic and translational research and by training young researchers in a state-of-the-art facilities, which provide a particularly stimulating scientific environment and strong research infrastructures.

At present, BRFAA consists of 4 Research Centers (Institutes) specialized in different aspects of Biomedical Research focusing on the following research areas: gene regulation, stem cells, neurobiology, developmental biology, aging, cancer, inflammation, stress and metabolic syndromes, cardiovascular pathophysiology and environmental health issues.

These research activities are being pursued in the context of the following Centers: (1) Center of Basic Research, (2) Center of Clinical and Translational Research, and Experimental Surgery (3) Center of Systems Biology and (4) Center of Environmental Health.

Research is performed by more than 50 research groups. Overall, more than 450 researchers including graduate students, postdoctoral fellows and technicians are pursuing their research activities at BRFAA and are supported by 52 administrators, financial officers and facilities maintenance personnel. BRFAA regularly hosts foreign researchers from across Europe and North America (both US and Canadian scientists). It is along these lines that the personnel involved in Experimental Surgery regularly offer training courses in large animal surgery that serve a number of European Universities, Hospitals and Research Institutions.RFAA research activities are supported by an impressive infrastructure of state-of-the-art core facilities, in addition to basic molecular biology equipment. All necessary heavy equipment to perform cutting-edge biomedical research are in place. Specifically, 22 modern molecular biology laboratories are supported by facilities for genomics, proteomics, flow-cytometry, cell sorting, laser capture microdissection, pharmacotechnology, advanced imaging (confocal and  deconvolution microscopy, micro-PET/CT animal imaging etc), transgenic and gene targeting animal facilities, histology suite and Bioinformatics services. Core facilities are run by experts in their fields and are supported by annual budgets for personnel and reagents provided by the Foundation and research grants. A state-of-the-art animal facility with individually ventilated cages that can house 20,000 mice as well as other animal species is in full operation. The Experimental Surgery unit is a state-of-the-art facility supporting any type of surgery and follow-up procedures. Veterinary supervision is available on a daily basis, and accreditation has already been obtained by the responsible European and National Committees.The Clinical Research infrastructure includes a 6-bed day clinic specialized in cardiovascular, metabolic, hematological and malignant diseases and is supported by the necessary medical personnel and infrastructure including a Positron Emission Tomography unit (PET-CT), echocardiography unit, cardiopulmonary exercise stress unit etc. It is notable that the Cord Blood Bank, which operates under the auspices of BRFAA, has made various contributions of stem cells, including several to the Children's University Hospital that were used successfully in transplantations for the treatment of cases of hematological malignancy cases Moreover, the Center for Environmental Health, which is linked to a satellite, monitors continuously climate changes (ozone levels, solar radiation and atmospheric pollutants).

Representatives

Research Scientist, Level A'

Biomedical Research Foundation of the Academy of Athens

Principal Scientist - Translational Biology

Biomedical Research Foundation of the Academy of Athens

Marketplace (1)

  • Project cooperation

    Translational PET/CT and PET/MR imaging: from mouse models to patients

    Quantitative PET imaging from mouse to patient: preclinical PET/CT with animal hosting, clinical PET/CT and PET/MR, and advanced image analysis for Cluster 1 Health 2027 proposals.

    • Partner seeks Consortium/Coordinator
    • Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
    • Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
    • Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
    • Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
    Author

    Research Scientist, Level A' at Biomedical Research Foundation of the Academy of Athens

    Athens, Greece